Mechanistically, DEFA5 induces cell cycle arrest by binding to BMI1, reducing its binding to the CDKN2a locus and upregulating the expression of the cyclin-dependent kinase inhibitors p16 and p19, therefore significantly increasing the number of cells in the G1 phase and inhibiting tumor growth (186). Here, CDKN2A is linked to neoplasm.